Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3148994690;94691;94692 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
N2AB2984889767;89768;89769 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
N2A2892186986;86987;86988 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
N2B2242467495;67496;67497 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
Novex-12254967870;67871;67872 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
Novex-22261668071;68072;68073 chr2:178547060;178547059;178547058chr2:179411787;179411786;179411785
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCA
  • RefSeq wild type template codon: CGT
  • Domain: Fn3-117
  • Domain position: 82
  • Structural Position: 114
  • Q(SASA): 0.4489
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/S rs773485371 -0.46 0.957 N 0.443 0.304 0.237489013734 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 5.57E-05 None 0 None 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.7942 likely_pathogenic 0.7672 pathogenic -0.908 Destabilizing 1.0 D 0.791 deleterious None None None None I
A/D 0.9943 likely_pathogenic 0.9931 pathogenic -0.654 Destabilizing 0.999 D 0.813 deleterious None None None None I
A/E 0.9837 likely_pathogenic 0.9807 pathogenic -0.81 Destabilizing 0.999 D 0.717 prob.delet. N 0.493663322 None None I
A/F 0.9259 likely_pathogenic 0.9237 pathogenic -0.938 Destabilizing 1.0 D 0.855 deleterious None None None None I
A/G 0.6065 likely_pathogenic 0.5435 ambiguous -0.327 Destabilizing 0.996 D 0.57 neutral N 0.491434823 None None I
A/H 0.9833 likely_pathogenic 0.9778 pathogenic -0.222 Destabilizing 1.0 D 0.834 deleterious None None None None I
A/I 0.7463 likely_pathogenic 0.7879 pathogenic -0.459 Destabilizing 1.0 D 0.766 deleterious None None None None I
A/K 0.9932 likely_pathogenic 0.9916 pathogenic -0.664 Destabilizing 0.999 D 0.731 prob.delet. None None None None I
A/L 0.8309 likely_pathogenic 0.8338 pathogenic -0.459 Destabilizing 0.998 D 0.715 prob.delet. None None None None I
A/M 0.8347 likely_pathogenic 0.8432 pathogenic -0.567 Destabilizing 1.0 D 0.785 deleterious None None None None I
A/N 0.9721 likely_pathogenic 0.9668 pathogenic -0.406 Destabilizing 0.999 D 0.815 deleterious None None None None I
A/P 0.9881 likely_pathogenic 0.9859 pathogenic -0.381 Destabilizing 1.0 D 0.767 deleterious D 0.530685207 None None I
A/Q 0.9649 likely_pathogenic 0.956 pathogenic -0.7 Destabilizing 1.0 D 0.799 deleterious None None None None I
A/R 0.9743 likely_pathogenic 0.9685 pathogenic -0.141 Destabilizing 1.0 D 0.784 deleterious None None None None I
A/S 0.2861 likely_benign 0.2606 benign -0.584 Destabilizing 0.957 D 0.443 neutral N 0.482929354 None None I
A/T 0.6451 likely_pathogenic 0.6555 pathogenic -0.667 Destabilizing 0.996 D 0.697 prob.neutral N 0.503173203 None None I
A/V 0.3793 ambiguous 0.4384 ambiguous -0.381 Destabilizing 0.998 D 0.745 deleterious N 0.508552597 None None I
A/W 0.9931 likely_pathogenic 0.9927 pathogenic -1.028 Destabilizing 1.0 D 0.832 deleterious None None None None I
A/Y 0.9738 likely_pathogenic 0.97 pathogenic -0.717 Destabilizing 1.0 D 0.85 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.